PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO.JK)
IDR 550.0
(0.92%)
IDR 550.0
(0.92%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.39 Billion IDR | 293.75% |
| 2022 | 2.38 Billion IDR | -72.49% |
| 2021 | 8.67 Billion IDR | 20.58% |
| 2020 | 7.19 Billion IDR | 0.0% |
| 2019 | - IDR | 0.0% |
| 2018 | - IDR | 0.0% |
| 2017 | - IDR | 0.0% |
| 2016 | - IDR | 0.0% |
| 2015 | - IDR | 0.0% |
| 2014 | - IDR | 0.0% |
| 2013 | - IDR | -100.0% |
| 2012 | 298.88 Billion IDR | 16.9% |
| 2011 | 255.67 Billion IDR | 8.14% |
| 2010 | 236.43 Billion IDR | 4.82% |
| 2009 | 225.57 Billion IDR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.89 Billion IDR | -43.81% |
| 2024 Q1 | 8.7 Billion IDR | -7.32% |
| 2024 Q3 | 3.3 Billion IDR | -32.53% |
| 2023 Q2 | 7.8 Billion IDR | 420.0% |
| 2023 Q1 | 1.5 Billion IDR | -37.11% |
| 2023 FY | 9.39 Billion IDR | 293.75% |
| 2023 Q4 | 9.39 Billion IDR | 0.0% |
| 2023 Q3 | 9.39 Billion IDR | 20.4% |
| 2022 FY | 2.38 Billion IDR | -72.49% |
| 2022 Q4 | 2.38 Billion IDR | -53.35% |
| 2022 Q1 | 8.09 Billion IDR | -6.61% |
| 2022 Q3 | 5.11 Billion IDR | -30.65% |
| 2022 Q2 | 7.37 Billion IDR | -8.94% |
| 2021 Q2 | 5.97 Billion IDR | -8.19% |
| 2021 Q1 | 6.5 Billion IDR | -9.5% |
| 2021 FY | 8.67 Billion IDR | 20.58% |
| 2021 Q4 | 8.67 Billion IDR | 31.56% |
| 2021 Q3 | 6.59 Billion IDR | 10.31% |
| 2020 Q3 | - IDR | 0.0% |
| 2020 Q1 | - IDR | 0.0% |
| 2020 Q4 | 7.19 Billion IDR | 0.0% |
| 2020 FY | 7.19 Billion IDR | 0.0% |
| 2020 Q2 | - IDR | 0.0% |
| 2019 Q1 | - IDR | 0.0% |
| 2019 FY | - IDR | 0.0% |
| 2019 Q3 | - IDR | 0.0% |
| 2019 Q2 | - IDR | 0.0% |
| 2019 Q4 | - IDR | 0.0% |
| 2018 FY | - IDR | 0.0% |
| 2018 Q4 | - IDR | 0.0% |
| 2018 Q3 | - IDR | 0.0% |
| 2018 Q2 | - IDR | 0.0% |
| 2018 Q1 | - IDR | 0.0% |
| 2017 Q1 | - IDR | 0.0% |
| 2017 Q2 | - IDR | 0.0% |
| 2017 Q3 | - IDR | 0.0% |
| 2017 Q4 | - IDR | 0.0% |
| 2017 FY | - IDR | 0.0% |
| 2016 Q3 | - IDR | 0.0% |
| 2016 FY | - IDR | 0.0% |
| 2016 Q4 | - IDR | 0.0% |
| 2016 Q2 | - IDR | 0.0% |
| 2016 Q1 | - IDR | 0.0% |
| 2015 Q1 | - IDR | 0.0% |
| 2015 FY | - IDR | 0.0% |
| 2015 Q4 | - IDR | 0.0% |
| 2015 Q3 | - IDR | 0.0% |
| 2015 Q2 | - IDR | 0.0% |
| 2014 Q4 | - IDR | -100.0% |
| 2014 Q3 | 7.51 Billion IDR | 0.0% |
| 2014 Q2 | - IDR | 0.0% |
| 2014 Q1 | - IDR | 0.0% |
| 2014 FY | - IDR | 0.0% |
| 2013 Q2 | 112.33 Billion IDR | 0.0% |
| 2013 Q1 | - IDR | 0.0% |
| 2013 FY | - IDR | -100.0% |
| 2013 Q4 | - IDR | 0.0% |
| 2012 FY | 298.88 Billion IDR | 16.9% |
| 2011 FY | 255.67 Billion IDR | 8.14% |
| 2010 FY | 236.43 Billion IDR | 4.82% |
| 2009 FY | 225.57 Billion IDR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 1.47 Billion IDR | -537.021% |
| PT Merck Tbk | 18.13 Billion IDR | 48.21% |
| PT Phapros, Tbk | 802.57 Billion IDR | 98.83% |
| PT Pyridam Farma Tbk | 986.99 Billion IDR | 99.049% |
| PT Tempo Scan Pacific Tbk | 1116.39 Billion IDR | 99.159% |